Expression of CTLA4-Ig by biolistically transfected mouse islets promotes islet allograft survival

Transplantation

Volumn 63, Issue 7, 1997, Pages 1017-1021

  Gainer, Anita L ^a   Korbutt, Gregory S ^a   Rajotte, Ray V ^a   Warnock, Garth L ^a   Elliott, John F ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; BIOLISTIC TRANSFORMATION; CONTROLLED STUDY; GENE EXPRESSION; GENE INSERTION; GENE THERAPY; GRAFT SURVIVAL; IMMEDIATE EARLY GENE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROMOTER REGION;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; BIOLISTICS; GRAFT SURVIVAL; HUMANS; IMMUNOCONJUGATES; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030935124     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199704150-00019     Document Type: Article

References (11)

1. Chahine AA, Yu M, McKernan MM, Stoeckert C, Lau HT. Immunomodulation of pancreatic islet allografts in mice with CTLA4Ig secreting muscle cells. Transplantation 1995; 59: 1313.
2. Lau HT, Yu M, Fontana A, Stoeckert CJ. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 1996; 273: 109.
3. Turka LA, Linsley PS, Lin H, et al. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci USA 1992; 89: 11102.
4. Lin H, Bolling Sf, Linsley PS, et al. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J Exp Med 1993; 178: 1801.
5. Pearson TC, Alexander DZ, Winn KJ, Linsley PS, Lowry RP, Larsen CP. Transplantation tolerance induced by CTLA4-Ig. Transplantation 1994; 57: 1701.
6. Steurer W, Nickerson PW, Steele AW, Steiger J, Zheng XX, Strom TB. Ex vivo coating of islet cell allografts with murine CTLA4/Fc promotes graft tolerance. J Immunol 1995; 155: 1165.
7. Gainer AL, Korbutt GS, Rajotte RV, Warnock GL, Elliott JF. Successful biolistic transformation of mouse pancreatic islets while preserving cellular function. Transplantation 1996; 61: 1567.
8. Gotoh M, Maki T, Kiyoizumi T, Satomi S, Monaco AP. An improved method for isolation of mouse pancreatic islets. Transplantation 1985; 40: 437.
9. Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991; 174: 561.
10. Lenschow DJ, Zeng Y, Thistlethwaite JR, et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 1992; 257: 789.
11. Suarez-Pinzon W, Rajotte RV, Mosmann TR, Rabinovitch A. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during β-cell destruction. Diabetes 1996; 45: 1350.